Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
暂无分享，去创建一个
J. Limacher | H. Wedemeyer | M. Romero-Gómez | R. Flisiak | G. Inchauspé | V. Carreño | C. Tănăsescu | C. Stanciu | G. Honnet | A. D. Di Bisceglie | W. Mazur | M. Toh | M. Hennequi | A. Fich | F. Habersetzer | Ewa Janczweska–Kazek | V. Bataille | P. Zerr | Delphine Agathon | G. Inchauspe | M. Romero‐Gomez | Marie Hennequi